Third line chemotherapy for unresectable advanced gastric cancer

被引:0
|
作者
Hosaka, H. [1 ]
Akiya, T. [2 ]
Fukai, Y. [1 ]
Sano, A. [1 ]
机构
[1] Gunma Canc Ctr, Gunma, Japan
[2] Fujioka Gen Hosp, Fujioka, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:226 / 226
页数:1
相关论文
共 50 条
  • [41] Role of Nivolumab in the Management of First-Line Unresectable Advanced or Recurrent Gastric Cancer in Combination with Chemotherapy: Lessons from the Japanese Experience
    Kubota, Yohei
    Aoki, Yu
    Kawazoe, Akihito
    Shitara, Kohei
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3083 - 3094
  • [42] The Value of Blood Tumor Markers in the Prognosis of Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer before First-line Chemotherapy
    SUN Zhi-wei
    JIA Jun
    DU Feng
    LIU Chuan-ling
    YU Jing
    YANG Ying
    XIAO Yan-jie
    ZHANG Xiao-dong
    Chinese Journal of Biomedical Engineering, 2019, 28 (01) : 1 - 12
  • [43] A network meta-analysis protocol of adjuvant chemotherapy for unresectable patients with advanced gastric cancer
    Li, Long
    Guo, Ling-yun
    Mao, Jie
    MEDICINE, 2019, 98 (28)
  • [44] Efficacy of the third-line chemotherapy in patients with advanced pancreatic cancer.
    Kim, Bomi
    Ahn, Jinwoo
    Jung, Jae Hyup
    Jung, Kwangrok
    Lee, Jong-Chan
    Hwang, Jin-Hyeok
    Kim, Jaihwan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 711 - 711
  • [45] Efficacy of Nab-Paclitaxel as Second-line Chemotherapy for Unresectable or Recurrent Gastric Cancer
    Fukuchi, Minoru
    Mochiki, Erito
    Ishiguro, Toru
    Ogura, Toshiro
    Sobajima, Jun
    Kumagai, Youichi
    Ishibashi, Keiichiro
    Ishida, Hideyuki
    ANTICANCER RESEARCH, 2016, 36 (12) : 6699 - 6703
  • [46] Efficacy and safety of irinotecan monotherapy as third line treatment for advanced gastric cancer
    Kawakami, Takeshi
    Machida, Nozomu
    Kawahira, Masahiro
    Kawai, Sadayuki
    Kito, Yosuke
    Yoshida, Yukio
    Hamauchi, Satoshi
    Tsushima, Takahiro
    Todaka, Akiko
    Yamazaki, Kentaro
    Yokota, Tomoya
    Fukutomi, Akira
    Onozawa, Yusuke
    Yasui, Hirofumi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [47] A retrospective analysis of third-line treatment in advanced gastric cancer.
    Ishizuka, Yasunobu
    Terazawa, Tetsuji
    Yukami, Hiroki
    Yamaguchi, Toshifumi
    Kuwakado, Shin
    Kii, Takayuki
    Goto, Masahiro
    Higuchi, Kazuhide
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [48] Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer
    Akitaka Makiyama
    Kohei Arimizu
    Gen Hirano
    Chinatsu Makiyama
    Yuzo Matsushita
    Tsuyoshi Shirakawa
    Hirofumi Ohmura
    Masato Komoda
    Keita Uchino
    Kyoko Inadomi
    Shuji Arita
    Hiroshi Ariyama
    Hitoshi Kusaba
    Yudai Shinohara
    Miyuki Kuwayama
    Tatsuhiro Kajitani
    Hisanobu Oda
    Taito Esaki
    Koichi Akashi
    Eishi Baba
    Gastric Cancer, 2018, 21 : 464 - 472
  • [49] Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer
    Makiyama, Akitaka
    Arimizu, Kohei
    Hirano, Gen
    Makiyama, Chinatsu
    Matsushita, Yuzo
    Shirakawa, Tsuyoshi
    Ohmura, Hirofumi
    Komoda, Masato
    Uchino, Keita
    Inadomi, Kyoko
    Arita, Shuji
    Ariyama, Hiroshi
    Kusaba, Hitoshi
    Shinohara, Yudai
    Kuwayama, Miyuki
    Kajitani, Tatsuhiro
    Oda, Hisanobu
    Esaki, Taito
    Akashi, Koichi
    Baba, Eishi
    GASTRIC CANCER, 2018, 21 (03) : 464 - 472